Paper10713596
EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.
Leight ER and 1 other. Rev Med Virol, 2000. Cited by 148 papers, by iCite.
Cite this record
ConductScience Library. EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Papers, record 10713596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10713596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epstein-Barr Virus Infections | Major topic |
| Epstein-Barr Virus Nuclear Antigens | Major topic |
| Herpesvirus 4, Human | Major topic |
| Virus Latency | Major topic |
| Animals | |
| Base Sequence | |
| Humans | |
| Molecular Sequence Data |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-07175 | NCI NIH HHS | United States | P01CA007175 | PubMed and NIH | NIH RePORTER |
| CA-22443 | NCI NIH HHS | United States | P01CA022443 | PubMed and NIH | NIH RePORTER |
| T32-CA-09135 | NCI NIH HHS | United States | T32CA009135 | PubMed and NIH | NIH RePORTER |
| P30CA007175 | NIH | NIH RePORTER |
Cited by89
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 148 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41673876 | Inhibition of death-ligand-induced apoptosis in Epstein-Barr virus-encoded small RNAs-expressing human T-cell line. | Infect Agent Cancer | 2026 | https://conductscience.org/library/papers/41673876 | PubMed |
| 41632332 | Molecular mechanisms of Epstein-Barr Virus in the pathogenesis of lymphomas and new opportunities for precision medicine. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41632332 | PubMed |
| 40685972 | EBV Latency Programs: Molecular and Epigenetic Regulation and Its Role in Disease Pathogenesis. | J Med Virol | 2025 | https://conductscience.org/library/papers/40685972 | PubMed |
| 40568704 | The emerging roles of ubiquitin-like modifications in regulating HIV replication and host defense. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40568704 | PubMed |
| 38675914 | Herpesvirus Infection of Endothelial Cells as a Systemic Pathological Axis in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. | Viruses | 2024 | https://conductscience.org/library/papers/38675914 | PubMed |
| 38596668 | The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape. | Front Immunol | 2024 | https://conductscience.org/library/papers/38596668 | PubMed |
| 38254110 | Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes. | Mol Cancer | 2024 | https://conductscience.org/library/papers/38254110 | PubMed |
| 38004636 | Establishment of Epstein-Barr Virus (EBV) Latent Gene-Expressing T-Cell Lines with an Expression Vector Harboring EBV Nuclear Antigen 1. | Microorganisms | 2023 | https://conductscience.org/library/papers/38004636 | PubMed |
| 37766341 | E3 Ubiquitin Ligases in Gammaherpesviruses and HIV: A Review of Virus Adaptation and Exploitation. | Viruses | 2023 | https://conductscience.org/library/papers/37766341 | PubMed |
| 37465179 | Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System. | Infect Drug Resist | 2023 | https://conductscience.org/library/papers/37465179 | PubMed |
| 37234394 | Epstein-Barr virus: the molecular virology and the associated diseases. | Fujita Med J | 2023 | https://conductscience.org/library/papers/37234394 | PubMed |
| 36830895 | Protein Kinase CK2 and Epstein-Barr Virus. | Biomedicines | 2023 | https://conductscience.org/library/papers/36830895 | PubMed |
| 36672418 | Role of Exosomes and Their Potential as Biomarkers in Epstein-Barr Virus-Associated Gastric Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36672418 | PubMed |
| 34794463 | Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein-Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders. | Virol J | 2021 | https://conductscience.org/library/papers/34794463 | PubMed |
| 34268333 | Structural and Biophysical Investigation of the Key Hotspots on the Surface of Epstein-Barr Nuclear Antigen 1 Essential for DNA Recognition and Pathogenesis. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/34268333 | PubMed |
| 32054837 | Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus. | Nat Commun | 2020 | https://conductscience.org/library/papers/32054837 | PubMed |
| 30842315 | Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth. | Sci Transl Med | 2019 | https://conductscience.org/library/papers/30842315 | PubMed |
| 30116721 | Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis. | Front Oncol | 2018 | https://conductscience.org/library/papers/30116721 | PubMed |
| 29996066 | Virus DNA Replication and the Host DNA Damage Response. | Annu Rev Virol | 2018 | https://conductscience.org/library/papers/29996066 | PubMed |
| 29632725 | SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts. | Oncoimmunology | 2018 | https://conductscience.org/library/papers/29632725 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10713596
GET https://conductscience.org/api/papers/v1/10713596/cited_by?page=2